In a previous study, we evaluated the role of host genetic markers (e.g., HLA-B, HLA-C, and KIR) in the risk and/or protection of TB-HIV coinfection outcomes, including the increased risk for TB-HIV/IRIS (de Sá et al., 2020). This evidence concerns the gene HLA-C and tuberculosis.